AHA: Registry Confirms Benefit of Drug-Eluting Stents
Cardiology
|
-
Currently 0.00/5
- 1
- 2
- 3
- 4
- 5
Rating: 0.0 out of 0 votes
Comments (0)
|
You need to have the
Flash Player installed and
a browser with JavaScript support.
Description
http://www.medpagetoday.com NEW ORLEANS, Nov. 11 -- Type 2 diabetes patients who had percutaneous coronary interventions with drug-eluting stents had lower two-year mortality, myocardial infarction, and revascularization rates than those given bare-metal devices researchers reported here.
|
Tags
|
Sign in or sign up to post comments.